GeminIQ Website Logo

Viewing SKIN free

Subscribe for full history, 90+ metrics, screener, watchlist...

SkinHealth Systems Inc.

SKIN

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
206204233219212373370359350445523559
Accounts Receivable Net Current
181922222523283641485567
Inventory Net
474848565966697377969175
Income Taxes Receivable
222320100101
Prepaid Expense And Other Assets Current
235578791621262936
Assets Current
295278310308306469477485490615698738
Property Plant And Equipment And Finance Lease Rig…
-233446810121416
Operating Lease Right Of Use Asset
192012141212141515161213
Finite Lived Intangible Assets Net
303336384346485154586265
Goodwill
126126127126126124123125125125126125
Deferred Income Tax Assets Net
222134413211
Other Assets Noncurrent
111112131314141516161616
Assets
487473500504508674686700712845929973
Liabilities And Stockhold…
Liabilities Current
Convertible Debt Current
103103124---0-----
Accounts Payable Current
161616172323222327374536
Employee Related Liabilities Current
131325191515181717152221
Operating Lease Liability Current
445555554555
Accrued Income Taxes Current
001133312332
Accrued Liabilities Current
321915191417202824242030
Liabilities Current
16815518662596368747594115126
Operating Lease Liability Noncurrent
181991181011121314910
Deferred Income Tax Liabilities Net
000000011112
Warrants And Rights Outstanding
---000011547
Convertible Debt Noncurrent
242241240363363553552551551665738737
Other Liabilities Noncurrent
222222212330
Liabilities
431418439438434628634640643781870883
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
584581580577575570567561553547541565
Accumulated Other Comprehensive Income Loss Net Of…
-1-2-1-2-2-6-7-4-5-4-3-5
Retained Earnings Accumulated Deficit
-527-524-517-509-498-518-508-498-479-480-479-469
Stockholders Equity
565561667446526069635990
Liabilities And Stockholders Equity
487473500504508674686700712845929973
Allowance For Doubtful Accounts Receivable Current
45678910118775
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
320320320320320320320320320320320320
Common Stock Shares Issued
130129128127127125125124124123123133
Shares Outstanding
130129128127127125125124124123123133

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-14.95%-27.47%-19.56%---------
202531.45%57.26%44.35%30.82%23.90%-12.58%14.73%13.18%18.60%-14.62%-18.58%-26.98%
2024-38.44%-46.52%-50.14%38.76%6.98%27.91%-11.76%-2.94%-1.76%-15.49%-19.72%14.79%
2023----13.90%-15.45%-36.24%117.27%98.56%114.39%3.34%-6.41%-38.44%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.76
1.79
1.66
4.98
5.15
7.47
7.00
6.56
6.49
6.57
6.07
5.86
Quick Ratio
1.34
1.45
1.37
3.95
4.02
6.31
5.85
5.35
5.19
5.27
5.03
4.98
Working Capital
127.04M
122.49M
123.24M
246.46M
246.67M
406.57M
408.97M
411.10M
414.20M
521.26M
583.24M
612.13M
Leverage & Debt
Debt to Equity
7.76
7.57
7.19
6.67
5.86
13.63
12.24
10.71
9.29
12.35
14.64
9.82
Interest Coverage TTM
-0.17
-0.46
-1.08
-1.82
-3.75
-6.36
-6.51
-6.98
-11.36
-9.85
-9.59
-8.40
Debt Ratio
0.89
0.88
0.88
0.87
0.85
0.93
0.92
0.91
0.90
0.93
0.94
0.91
Efficiency & Turnover
Asset Turnover TTM
0.58
0.52
0.51
0.50
0.51
0.42
0.41
0.42
0.43
0.43
0.41
0.38
Days Sales Outstanding TTM
26.86
25.81
29.96
35.35
39.11
40.14
44.95
54.12
57.83
54.99
60.16
68.92
Receivables Turnover TTM
13.59
14.14
12.18
10.32
9.33
9.09
8.12
6.74
6.31
6.64
6.07
5.30
Per Share Metrics
Diluted EPS TTM
-0.22
-0.05
-0.07
-0.09
-0.14
-0.31
-0.20
-0.23
-0.59
-0.56
-0.76
-0.63
Free Cash Flow Per Share TTM
0.23
0.22
0.29
0.28
0.29
0.28
0.12
-0.05
0.01
0.13
0.14
0.13
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
66.35%
64.91%
65.28%
64.81%
61.50%
56.60%
54.53%
50.53%
33.43%
38.00%
38.97%
44.06%
Operating Profit Margin TTM
-1.49%
-3.57%
-6.92%
-9.31%
-14.00%
-19.48%
-20.27%
-22.72%
-38.11%
-33.22%
-32.89%
-28.80%
Net Profit Margin TTM
-9.80%
-2.04%
-3.16%
-3.89%
-6.13%
-11.94%
-8.70%
-8.10%
-22.85%
-20.49%
-25.16%
-21.08%
Growth Metrics
Net Revenue Growth (1Y)
-6.46%
-8.17%
-10.02%
-13.15%
-15.34%
-17.97%
-16.00%
-12.94%
-6.26%
4.35%
8.78%
15.53%
Net Income Growth (1Y)
49.61%
-84.28%
-67.29%
-58.31%
-77.29%
-52.18%
-70.94%
-66.53%
701.47%
975.25%
-326.38%
-513.05%
EPS Growth (1Y)
45.54%
-84.62%
-67.95%
-59.24%
-77.72%
-52.93%
-69.09%
-64.15%
759.76%
1,056.47%
-353.67%
-568.66%
Valuation Metrics
P/E TTM
-3.16
-18.79
-18.45
-21.50
-12.67
-4.35
-6.77
-6.34
-2.84
-6.79
-4.09
-9.50
P/B TTM
1.62
2.06
2.88
3.85
3.25
3.64
3.80
2.99
3.43
8.64
6.90
8.89
P/S TTM
0.31
0.38
0.58
0.84
0.78
0.52
0.59
0.51
0.65
1.39
1.03
2.00
Market Cap
89.81M
113.74M
175.67M
252.51M
240.80M
167.61M
196.89M
178.64M
237.54M
546.65M
409.53M
800.04M
Enterprise Value
228.95M
253.60M
307.38M
396.50M
391.89M
347.56M
379.02M
371.16M
438.62M
767.51M
624.87M
977.91M
Calculated Values
Free Cash Flow TTM
29.87M
28.45M
37.18M
35.57M
36.26M
35.53M
15.38M
-6.22M
1.26M
16.06M
17.93M
16.76M
Net Debt
139.14M
139.86M
131.72M
143.99M
151.10M
179.95M
182.14M
192.52M
201.08M
220.85M
215.35M
177.87M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-11-20Sale
Owner: Gruber, Desiree
Title: -
Shares: 14,663
Price/Share: $1.50
Value: $21,994.50
Shares Owned: 119,514
Relationship: Director
Ownership: Direct
2024-08-12Purchase
Owner: Saunders, Brent L
Title: -
Shares: 40,450
Price/Share: $1.08
Value: $43,686.00
Shares Owned: 5,921,769
Relationship: Director,Other
Ownership: Direct
2023-08-17Purchase
Owner: Stanleick, Andrew Roy
Title: Chief Executive Officer
Shares: 16,485
Price/Share: $6.05
Value: $99,734.25
Shares Owned: 702,933
Relationship: Director,Officer
Ownership: Direct
2023-08-17Purchase
Owner: Capellas, Michael D
Title: -
Shares: 30,000
Price/Share: $6.03
Value: $180,900.00
Shares Owned: 197,612
Relationship: Director
Ownership: Direct
2023-08-17Purchase
Owner: Miller, Brian Christopher
Title: -
Shares: 60,000
Price/Share: $5.81
Value: $348,600.00
Shares Owned: 91,450
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
60.82%
Inst. Shares: 77,728,913
Shares Outstanding: 127,792,611
2025-12-31
62.74%
Inst. Shares: 79,288,400
Shares Outstanding: 126,378,509
2025-09-30
61.76%
Inst. Shares: 78,364,762
Shares Outstanding: 126,890,888
2025-06-30
58.77%
Inst. Shares: 74,093,129
Shares Outstanding: 126,072,603
2025-03-31
56.21%
Inst. Shares: 70,309,913
Shares Outstanding: 125,079,470

SkinHealth Systems Inc. (SKIN) — SEC Financial Statements & Analysis

SkinHealth Systems Inc. (SKIN) is a surgical & medical instruments & apparatus company, incorporated in DE. SkinHealth Systems Inc. trades on Nasdaq as: SKIN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SkinHealth Systems Inc. reported a -6.46% year-over-year revenue growth, a Gross Profit Margin of 66.35% (TTM), a Debt-to-Equity ratio of 7.76x, a Price-to-Sales (P/S) ratio of 0.31x (TTM), a Price-to-Book (P/B) ratio of 1.62x (TTM), at a market cap of $89.81M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-6.46%
Gross Profit Margin TTM
66.35%
Debt To Equity
7.76x
P/S TTM
0.31x
P/B TTM
1.62x
Market Cap
$89.81M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SkinHealth Systems Inc. in?

SkinHealth Systems Inc. (SKIN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SKIN's market cap?

SkinHealth Systems Inc. (SKIN) has a market capitalization of $89.81M as of 2026-06-30.

What exchange does SKIN trade on?

SkinHealth Systems Inc. (SKIN) trades on the Nasdaq.

Where is SkinHealth Systems Inc. incorporated?

SkinHealth Systems Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.